Professor, Internal Medicine, Oakland University Wm Beaumont SOM
Endocrinology
Dr. Henry G. Bone III, MD
|
|
Give Review
Henry Bone is an expert in the field of Endocrinology. He graduated from University of Washington School of Medicine. He received awards:"Top MD", "Super Doctor" and "Fellow (FACE)". Henry Bone has written publications. He has 38 publications published with PubMed. The lastest publication is: 'Erratum to: Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacat...' He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Erratum to: Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacat...
- Cinacalcet normalizes serum calcium in a double-blind randomized, placebo-controlled study in patients with primary hyperparaThyroidism with contraindications to surgery.
- Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture ...
- Paget's Disease of Bone: An Endocrine Society Clinical Practice Guideline.
- Denosumab significantly increases bone mineral density and reduces bone turnover compared with monthly oral ibandronate and risedronate in postmenopausal women who rem...
- Romosozumab in Postmenopausal Women with Low Bone Mineral Density.
- The Effect of Three or Six Years of Denosumab Exposure in Women With Postmenopausal Osteoporosis: Results From the FREEDOM Extension.
- Comment on journal review of 'Use of depot medroxyprogesterone acetate contraception and incidence of bone fracture'.
- Effects of Pioglitazone on Bone in Postmenopausal Women With Impaired Fasting Glucose or Impaired Glucose Tolerance: A Randomized, Double-Blind, Placebo-Controlled Study.
- Denosumab compared with ibandronate in postmenopausal women previously treated with bisphosphonate therapy: a randomized open-label trial.
- Improved adherence with PTH(1-84) in an extension trial for 24 months results in enhanced BMD gains in the treatment of postmenopausal women with osteoporosis.
- Use of Depot Medroxyprogesterone Acetate Contraception and Incidence of Bone Fracture.
- Future directions in osteoporosis therapeutics.
- The Effects of Ronacaleret, a Calcium-Sensing Receptor Antagonist, on Bone Mineral Density and Biochemical Markers of Bone Turnover in Postmenopausal Women with Low Bo...
- Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone mass.
- Odanacatib in the treatment of postmenopausal women with low bone mineral density: three-year continued therapy and resolution of effect.
- Odanacatib, a cathepsin-K inhibitor for osteoporosis: a two-year study in postmenopausal women with low bone density.
- Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy.
- Comparison of the Effect of Denosumab and Alendronate on Bone Mineral Density and Biochemical Markers of Bone Turnover in Postmenopausal Women With Low Bone Mass: A Ra...
- Four-month treatment with GLP-2 significantly increases hip BMD: a randomized, placebo-controlled, dose-ranging study in postmenopausal women with low BMD.
- Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded...
- Randomized trial of denosumab in patients receiving adjuvant aromatase inhibitors for nonmetastatic breast cancer.
- Effects of denosumab on bone mineral density and bone turnover in postmenopausal women.
- Sequestosome 1 (SQSTM1) mutations in Paget's Disease of bone from the United States.
- Adherence to and gastrointestinal tolerability of monthly oral or quarterly intravenous ibandronate therapy in women with previous intolerance to oral bisphosphonates:...
- Longitudinal study of depot medroxyprogesterone acetate (Depo-Provera) effects on bone health in adolescents: study design, population characteristics and baseline bon...
- Effects of atorvastatin on bone in postmenopausal women with dysLipidemia: a double-blind, placebo-controlled, dose-ranging trial.
- A cross-sectional study of bone turnover markers in healthy premenopausal women.
- Disassociation of bone resorption and formation by GLP-2: a 14-day study in healthy postmenopausal women.
- Nonmalignant complications of Paget's Disease.
- Are we treating women with postmenopausal osteoporosis for their low BMD or high fracture risk?
- Intravenous bisphosphonate therapy for osteoporosis: where do we stand?
- Reduction of nocturnal rise in bone resorption by subcutaneous GLP-2.
- Pins and plaster aren't enough: a call for the evaluation and treatment of patients with osteoporotic fractures.
- Therapeutic equivalence of alendronate 35 milligrams once weekly and 5 milligrams daily in the prevention of postmenopausal osteoporosis.
- Identification of a novel tandem duplication in exon 1 of the TNFRSF11A gene in two unrelated patients with familial expansile osteolysis.
- Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteopo...
Schools
University of Washington
Parkland Memorial Hospital
VA Hospital
University Tex Med Center
Conditions Treated
- Abnormal Thyroid
- Acromegaly and Gigantism
- Adrenal Insufficiency
- Calcium Metabolism Disorders
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
Awards
- Top MD
- Super Doctor
- Fellow (FACE)
Education
-
University of Washington School of Medicine
Hospital
-
St. John Hospital and Medical Center
Helpful Reviews
Similar Doctors
|
|
Dr. Regina T. Kurian, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rana Alsabbagh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephenie M. Lucas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Akin N. Eraslan, MD |
|
|
Dr. Saadiah M. Ahmed, DO |
|
|
Dr. Joan M. Pinto, MD
This Doctor is OpenDoctor Recommended.
|